Surrozen, Inc./DE

Ownership Transactions Reported by 24 Insiders

Symbol
SRZN, SRZNW on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
171 Oyster Point Blvd, Suite 400, South San Francisco, CA

Insiders trading volume in the past year

Surrozen, Inc./DE executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Tim Kutzkey Director $32M Mar 26, 2025
Column Group III Gp, Lp 10%+ Owner $27.7M +$16M +137% Nov 13, 2025
Consonance Life Sciences Former 10% Holder $716K Aug 11, 2021
Kevin Livingston Former Chief Financial Officer $716K Aug 11, 2021
Benny Soffer Former Director $716K Aug 11, 2021
Yang Li Exec. Vice President, Research $111K -$14.6K -11.6% Jun 13, 2025
Williams Charles O CFO and COO $75.6K -$20.5K -21.3% Jun 13, 2025
Craig C. Parker Chief Executive Officer, Director $56.6K Jun 13, 2025
Geertrui Vanhove Chief Medical Officer $12.3K Dec 15, 2022
Jennifer Jarrett Former Director $11.4K Aug 11, 2021
Donald J. Santel Former Director $11.4K Aug 11, 2021
Christopher Haqq Former Director $11.4K Aug 11, 2021
Yeh Wen-Chen Chief Scientific Officer $10.3K Jun 15, 2023
Shao-Lee Lin Director May 14, 2025
Christopher Chai Director May 14, 2025
David J. Woodhouse Director May 14, 2025
Eric Bjerkholt Director May 14, 2025
Mace Rothenberg Director May 14, 2025
Andrew Pedrum Maleki Chief Financial Officer Nov 12, 2025
Anna Berkenblit Director May 14, 2025
Gad Soffer Former Chief Executive Officer Aug 11, 2021
Mitchell Blutt 10%+ Owner Dec 14, 2022
Joshua Cory House Former VP Business Development Aug 11, 2021
Mary Haak-Frendscho Director May 14, 2025

Recent Insider Transactions by Companies or Individuals for Surrozen, Inc./DE

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.